Evolent Health (EVH) stock price, chart and financials

Price chart

Revenue (trailing twelve months)

$2.1B

Revenue (quarter)

$652.5M

Revenue growth (year over year)

+46.86%

Gross profit (trailing twelve months)

$361.6M

Gross margin

17.25%

Net income (trailing twelve months)

−$505.0M

Net income (quarter)

−$28.4M

Net income growth (year over year)

−42.55%

Net margin

−24.08%

Return on equity

−79.90%

EPS (trailing twelve months)

−$4.49

Book value per share

$3.40

P/E (trailing twelve months)

—

Price to book

1.40

Debt to assets

80.57%

Payout ratio

—

Dividend yield

—

Company profile

Evolent Health Inc is engaged in healthcare delivery and payment. The company supports health systems and physician organizations in their migration toward value-based care and population health management. It provides specialty care management services in oncology, cardiology, musculoskeletal markets and holistic total cost of care management along with an integrated platform for health plan administration and value-based business infrastructure under one go to market package. The solutions provided by the company includes: Oncology, Cardiology, Musculoskeletal, Administrative Services, Advanced Illness, Genetic Testing, Physical Medicine, Radiology, and Surgical Management.

• Is Evolent Health (EVH) profitable?

  No. Evolent Health reported a net loss of $505.0M over the trailing twelve months.

• How much revenue does Evolent Health (EVH) make?

  Evolent Health generated $2.1B in revenue over the trailing twelve months, up 46.86% year over year.

• How do I buy stock in Evolent Health (EVH)?

  EVH trades commission-free with a Light Horse Securities brokerage account — from the mobile app, the web at Light Horse Dashboard, the trading API, or an AI agent connected over MCP. The trade panel on this page places the order once you are signed in.